Covishield production in full swing, says SII CEO Adar Poonawalla

Coronavirus chronicle

TBS Report
02 May, 2021, 09:45 am
Last modified: 02 May, 2021, 12:02 pm
SII dropped the price of its Covid-19 vaccine, dubbed "Covishield," from $400 to $300 per dose for states
Photo: NDTV

CEO of the Serum Institute of India (SII) Adar Poonawalla on Saturday night said that the development of the Covid-19 vaccine Covishield is in full swing in Pune, after a meeting with his associates and stakeholders in the United Kingdom. 

Poonawalla in a tweet said, "Had an excellent meeting with all our partners & stakeholders in the UK. Meanwhile, pleased to state that COVISHIELD's production is in full swing in Pune. I look forward to reviewing operations upon my return in a few days."

On Wednesday, SII dropped the price of its Covid-19 vaccine, dubbed "Covishield," from ₹400 to ₹300 per dose for states, reports Hindustan Times.

Poonawalla was also given Y category protection by the Central Reserve Police Force on Wednesday by the Ministry of Home Affairs (MHA) (CRPF).

Adar Poonawalla had requested financial assistance from the government earlier this month in order to increase vaccine production.

Related Topics

World+Biz / South Asia

Serum Institute of India (SII) / CEO / Adar Poonawalla

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.